Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 132

    1.

    Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem.

    Kark JD, Selhub J, Adler B, Gofin J, Abramson JH, Friedman G, Rosenberg IH.

    Ann Intern Med. 1999 Sep 7;131(5):321-30.PMID: 10475884 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study.

    Vollset SE, Refsum H, Tverdal A, Nygård O, Nordrehaug JE, Tell GS, Ueland PM.

    Am J Clin Nutr. 2001 Jul;74(1):130-6.PMID: 11451728 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

    Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, Jacques PF, Wilson PW.

    Arch Intern Med. 1999 May 24;159(10):1077-80.PMID: 10335684 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem.

    Calderon-Margalit R, Adler B, Abramson JH, Gofin J, Kark JD.

    Clin Chem. 2006 May;52(5):845-52. Epub 2006 Mar 9.PMID: 16527886 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Siesta and mortality in a Mediterranean population: a community study in Jerusalem.

    Burazeri G, Gofin J, Kark JD.

    Sleep. 2003 Aug 1;26(5):578-84.PMID: 12938811 [PubMed - indexed for MEDLINE]Related articles

    6.

    Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study.

    Bostom AG, Rosenberg IH, Silbershatz H, Jacques PF, Selhub J, D'Agostino RB, Wilson PW, Wolf PA.

    Ann Intern Med. 1999 Sep 7;131(5):352-5.PMID: 10475888 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.

    Ndrepepa G, Kastrati A, Braun S, Koch W, Kölling K, Mehilli J, Schömig A.

    Clin Chim Acta. 2006 Nov;373(1-2):70-6. Epub 2006 May 16.PMID: 16814762 [PubMed - indexed for MEDLINE]Related articles

    9.

    Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study.

    Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I.

    JAMA. 2006 Sep 13;296(10):1255-65.PMID: 16968850 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The relationship of coffee consumption with mortality.

    Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB.

    Ann Intern Med. 2008 Jun 17;148(12):904-14.PMID: 18559841 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Dispositional optimism and all-cause and cardiovascular mortality in a prospective cohort of elderly dutch men and women.

    Giltay EJ, Geleijnse JM, Zitman FG, Hoekstra T, Schouten EG.

    Arch Gen Psychiatry. 2004 Nov;61(11):1126-35.PMID: 15520360 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

    Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A.

    JAMA. 2005 Oct 12;294(14):1799-809. Erratum in: JAMA. 2005 Dec 14;294(22):2848. PMID: 16219884 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus.

    Soinio M, Marniemi J, Laakso M, Lehto S, Rönnemaa T.

    Ann Intern Med. 2004 Jan 20;140(2):94-100.PMID: 14734331 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem.

    Kark JD, Sinnreich R, Rosenberg IH, Jacques PF, Selhub J.

    Circulation. 2002 Jun 11;105(23):2725-9.PMID: 12057985 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction.

    Vasan RS, Beiser A, D'Agostino RB, Levy D, Selhub J, Jacques PF, Rosenberg IH, Wilson PW.

    JAMA. 2003 Mar 12;289(10):1251-7.PMID: 12633186 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

    Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM; Veterans Affairs Site Investigators.

    JAMA. 2007 Sep 12;298(10):1163-70. Erratum in: JAMA. 2008 Jul 9;300(2):170. PMID: 17848650 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition.

    Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, Day N.

    Lancet. 2001 Mar 3;357(9257):657-63.PMID: 11247548 [PubMed - indexed for MEDLINE]Related articles

    18.

    Plasma carotene and alpha-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA).

    Buijsse B, Feskens EJ, Schlettwein-Gsell D, Ferry M, Kok FJ, Kromhout D, de Groot LC.

    Am J Clin Nutr. 2005 Oct;82(4):879-86.PMID: 16210720 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Plasma homocysteine levels and mortality in patients with coronary artery disease.

    Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE.

    N Engl J Med. 1997 Jul 24;337(4):230-6.PMID: 9227928 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study.

    Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL.

    Ann Epidemiol. 2000 Oct;10(7):441-8.PMID: 11023623 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data